高密度脂蛋白胆固醇和认知功能在老年韩国成年人没有痴呆症:Apolipoprotein E4作为一个调节因素
Young Min Choe1,2, Hye Ji Choi1, Musung Keum1
1Department of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil, Hwaseong 18450, Gyeonggi, Republic of Korea.
Nutrients
|July 30, 2025
概括
较高的高密度脂蛋白胆固醇 (HDL-C) 水平与更好的认知功能相关,特别是情节性记忆. 这种关联在具有阿波利波蛋白E ε4 (APOE4) 基因变异的个体中更为强烈,这表明它可能具有神经保护作用.
科学领域:
- 神经科学是一个神经科学.
- 心血管科学 心血管科学
- 遗传学 是一个遗传学.
背景情况:
- 高密度脂蛋白胆固醇 (HDL-C) 有已知的心血管和神经保护性益处,但它与认知功能的联系,特别是考虑到阿波利波蛋白E ε4 (APOE4) 等遗传因素,尚未完全理解.
- APOE4是认知能力下降和阿尔茨海默病的重要遗传风险因素.
研究的目的:
- 调查血清HDL-C水平与老年人认知功能之间的关联.
- 检查APOE4状态是否能缓和HDL-C与认知之间的关系.
主要方法:
- 对196名65至90岁的没有痴呆症的成年人进行了横截面研究.
- 使用CERAD电池评估认知功能;测量血清HDL-C;进行APOE4基因定型.
- 多重线性回归分析调整了各种人口,临床和生活方式因素.
主要成果:
- 较高的HDL-C水平与更好的情节性记忆和全球认知功能有显著的关联.
- APOE4 状态显著缓解了这些关联.
- 在APOE4阳性个体中,HDL-C与情节性记忆和全球认知有着强烈的积极关联,而在APOE4阴性个体中没有观察到这一点.
结论:
- 血清HDL-C水平与认知功能显著相关,特别是情节性记忆和全球认知.
- APOE4 状态似乎可以缓解这种关联,这表明HDL-C可能会在具有这种遗传风险因素的个体中提供更大的认知保护.
- 需要进一步的纵向和机制研究来确认因果关系并探索临床影响.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在阿波利波蛋白E ε4等位基因中.认知功能 认知功能这是一种情节性记忆 (episodic memory).高密度脂蛋白胆固醇是高密度脂蛋白胆固醇的一种.更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.4K
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.9K
相关概念视频
01:26Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
01:30Cognitive Development During Adulthood
282
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
282
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
208
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
208
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:26Coronary Artery Disease IV: Preventive Measures
35
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
35
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262